Indication
Cystic fibrosis with homozygous F508del mutation in CFTR gene
Cystic fibrosis with a homozygous F508del mutation in the CFTR gene is an autosomal recessive, multi-organ genetic disorder characterized by the presence of two identical copies of the class II deletion of phenylalanine at position 508 in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene. Read more about Cystic fibrosis with homozygous F508del mutation in CFTR gene
5 drugs 1 manufacturers
Drugs that treat it
Common Cystic fibrosis with homozygous F508del mutation in CFTR gene therapies.
SYMDEKO (tezacaftor/ivacaftor)
ORKAMBI (lumacaftor/ivacaftor)
TRIKAFTA (elexacaftor/tezacaftor/ivacaftor)
ALYFTREK (vanzacaftor calcium/tezacaftor/deutivacaftor)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCystic fibrosis with a homozygous F508del mutation in the CFTR gene is an autosomal recessive, multi-organ genetic disorder characterized by the presence of two identical copies of the class II deletion of phenylalanine at position 508 in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene.
This specific genotype leads to abnormal protein folding and premature endoplasmic reticulum degradation, severely depleting functional chloride and bicarbonate channels at epithelial apical surfaces across the respiratory, gastrointestinal, pancreatic, hepatobiliary, and reproductive tracts.
The resulting defect impairs epithelial ion and fluid transport, driving the accumulation of thick, dehydrated secretions that precipitate chronic airway obstruction, recurrent bronchopulmonary infections, bronchiectasis, and progressive exocrine pancreatic insufficiency.
- nih.gov
Cystic fibrosis with a homozygous F508del mutation in the CFTR gene is an autosomal recessive, multi-organ genetic disorder characterized by the presence of two identical copies of the class II deletion of phenylalanine at position 508 in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene This specific genotype leads to abnormal protein folding and premature endoplasmic reticulum degradation, severely depleting functional chloride and bicarbonate channels at epithelial apical ...
- youtube.com
Cystic fibrosis with a homozygous F508del mutation in the CFTR gene is an autosomal recessive, multi-organ genetic disorder characterized by the presence of two identical copies of the class II deletion of phenylalanine at position 508 in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene This specific genotype leads to abnormal protein folding and premature endoplasmic reticulum degradation, severely depleting functional chloride and bicarbonate channels at epithelial apical ...
- nih.gov
Cystic fibrosis with a homozygous F508del mutation in the CFTR gene is an autosomal recessive, multi-organ genetic disorder characterized by the presence of two identical copies of the class II deletion of phenylalanine at position 508 in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene
- nih.gov
This specific genotype leads to abnormal protein folding and premature endoplasmic reticulum degradation, severely depleting functional chloride and bicarbonate channels at epithelial apical surfaces across the respiratory, gastrointestinal, pancreatic, hepatobiliary, and reproductive tracts The resulting defect impairs epithelial ion and fluid transport, driving the accumulation of thick, dehydrated secretions that precipitate chronic airway obstruction, recurrent bronchopulmonary infections, b...
- e-century.us
The resulting defect impairs epithelial ion and fluid transport, driving the accumulation of thick, dehydrated secretions that precipitate chronic airway obstruction, recurrent bronchopulmonary infections, bronchiectasis, and progressive exocrine pancreatic insufficiency
Personalize your experience
Follow Cystic fibrosis with homozygous F508del mutation in CFTR gene and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.